190 related articles for article (PubMed ID: 32101273)
21. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
22. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
Plaza Reyes A; Lanner F
Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
[TBL] [Abstract][Full Text] [Related]
23. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
Pei WD; Zhang Y; Yin TL; Yu Y
Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
25. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma.
Hong L; Zhang C; Jiang Y; Liu H; Huang H; Guo D
Future Oncol; 2020 Jun; 16(16):1125-1136. PubMed ID: 32338048
[TBL] [Abstract][Full Text] [Related]
27. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
28. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
29. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
30. [CRISPR-Cas9, germinal cells and human embryo].
Jouannet P
Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
Jacinto FV; Link W; Ferreira BI
J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
[TBL] [Abstract][Full Text] [Related]
32. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
[TBL] [Abstract][Full Text] [Related]
33. [A new milestone in human embryo editing].
Jordan B
Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
[TBL] [Abstract][Full Text] [Related]
34. Advances in therapeutic application of CRISPR-Cas9.
Sun J; Wang J; Zheng D; Hu X
Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
[TBL] [Abstract][Full Text] [Related]
35. The New RNA-Editing Era - Ethical Considerations.
Gold A; Levanon EY; Eisenberg E
Trends Genet; 2021 Aug; 37(8):685-687. PubMed ID: 33975753
[TBL] [Abstract][Full Text] [Related]
36. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
Zhang X; Cheng C; Sun W; Wang H
Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
38. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
Luo X; Li M; Su B
Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
[TBL] [Abstract][Full Text] [Related]
39. CRISPR as a driving force: the Model T of biotechnology.
Mariscal C; Petropanagos A
Monash Bioeth Rev; 2016 Jun; 34(2):101-116. PubMed ID: 27619650
[TBL] [Abstract][Full Text] [Related]
40. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
